These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30782874)

  • 1. Evaluation of the overdiagnosis in breast screening programmes using a Monte Carlo simulation tool: a study of the influence of the parameters defining the programme configuration.
    Forastero C; Zamora LI; Guirado D; Lallena AM
    BMJ Open; 2019 Feb; 9(2):e023187. PubMed ID: 30782874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
    Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
    Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of overdiagnosis in breast cancer screening using a non-homogeneous multi-state model: A simulation study.
    Wu WY; Nyström L; Jonsson H
    J Med Screen; 2018 Dec; 25(4):183-190. PubMed ID: 29153013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
    Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
    BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
    [No Abstract]   [Full Text] [Related]  

  • 6. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
    Michalopoulos D; Duffy SW
    J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.
    Duffy SW; Agbaje O; Tabar L; Vitak B; Bjurstam N; Björneld L; Myles JP; Warwick J
    Breast Cancer Res; 2005; 7(6):258-65. PubMed ID: 16457701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overdiagnosis in breast imaging.
    Evans A; Vinnicombe S
    Breast; 2017 Feb; 31():270-273. PubMed ID: 28029492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights Into Breast Cancer Screening: A Computer Simulation of Two Contemporary Screening Strategies.
    Carter KJ; Castro F; Morcos RN
    AJR Am J Roentgenol; 2018 Mar; 210(3):564-571. PubMed ID: 29323554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer.
    van Luijt PA; Rozemeijer K; Naber SK; Heijnsdijk EA; van Rosmalen J; van Ballegooijen M; de Koning HJ
    J Med Screen; 2016 Dec; 23(4):210-216. PubMed ID: 27068430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
    Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
    Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An Update.
    Lee SJ; Li X; Huang H; Zelen M
    Med Decis Making; 2018 Apr; 38(1_suppl):44S-53S. PubMed ID: 29554465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overdiagnosis and Risks of Breast Cancer Screening.
    Neal CH; Helvie MA
    Radiol Clin North Am; 2021 Jan; 59(1):19-27. PubMed ID: 33222997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will supplemental screening ultrasound increase breast cancer overdiagnosis?
    Molleran VM
    Acad Radiol; 2015 Aug; 22(8):967-72. PubMed ID: 26100187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Overdiagnosis in mammography screening for breast cancer].
    Huang YB; Yang L; Song FJ; Chen KX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Nov; 38(11):1574-1578. PubMed ID: 29141352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom.
    Gunsoy NB; Garcia-Closas M; Moss SM
    Breast Cancer Res; 2012 Nov; 14(6):R152. PubMed ID: 23194032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overdiagnosis associated with breast cancer screening: A simulation study to compare lead-time adjustment methods.
    Seigneurin A; Labarère J; Duffy SW; Colonna M
    Cancer Epidemiol; 2015 Dec; 39(6):1128-35. PubMed ID: 26341587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Discrepancies and overdiagnosis in breast cancer organized screening. A "methodology" systematic review].
    Gocko X; Leclerq M; Plotton C
    Rev Epidemiol Sante Publique; 2018 Nov; 66(6):395-403. PubMed ID: 30316554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overdiagnosis of breast cancer at screening is clinically insignificant.
    Feig SA
    Acad Radiol; 2015 Aug; 22(8):961-6. PubMed ID: 25797300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.